Korea Dumps 2.54 Million Doses Of Flu Vaccine, Losing $24.68 Million, Drawing Ire From Lawmakers
This article was originally published in PharmAsia News
Executive Summary
SEOUL - A ruling party lawmaker in South Korea claims the government's excess of flu vaccines has resulted in a loss of KRW 28.6 billion ($24.68 million) in government budgetary spending as it had to discard 2.54 million doses of the flu vaccines it secured from local vaccine maker Green Cross
You may also be interested in...
Korean Government Takes Precautionary Steps Against Pandemic Repeat
SEOUL - Hoping to avoid a recurrence of the influenza A/H1N1 pandemic from a year ago, South Korea's Ministry of Health and Welfare called on the country's senior citizens and the underprivileged to get free-of-charge flu vaccines beginning early October
Korean Government Takes Precautionary Steps Against Pandemic Repeat
SEOUL - Hoping to avoid a recurrence of the influenza A/H1N1 pandemic from a year ago, South Korea's Ministry of Health and Welfare called on the country's senior citizens and the underprivileged to get free-of-charge flu vaccines beginning early October
Daiichi Sankyo and Biota Bring Next-gen Flu Drug To Japan; Continue Search For Western Partner
TOKYO - Daiichi Sankyo has received marketing and manufacturing approval in Japan for its second-generation long-acting neuraminidase inhibitor Inavir (laninamivir), bringing encouraging news to Daiichi Sankyo and Australian partner Biota, which have faced delays in snagging an ex-Japan partner for the drug